Sphingosine-1-Phosphate Signaling in Ischemic Stroke: From Bench to Bedside and Beyond
Sphingosine-1-phosphate (S1P) signaling is being increasingly recognized as a strong modulator of immune cell migration and endothelial function. Fingolimod and other S1P modulators in ischemic stroke treatment have shown promise in emerging experimental models and small-scale clinical trials. In th...
Guardado en:
Autores principales: | Shuo-Qi Zhang, Jun Xiao, Man Chen, Luo-Qi Zhou, Ke Shang, Chuan Qin, Dai-Shi Tian |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9910cb777bb346ada2f1b6f23b2b6835 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sphingosine Kinase 1 Signaling in Breast Cancer: A Potential Target to Tackle Breast Cancer Stem Cells
por: Ling-Wei Hii, et al.
Publicado: (2021) -
Signaling through the S1P−S1PR Axis in the Gut, the Immune and the Central Nervous System in Multiple Sclerosis: Implication for Pathogenesis and Treatment
por: Simela Chatzikonstantinou, et al.
Publicado: (2021) -
Increased Sphingosine-1-Phosphate Serum Concentrations in Subjects with Periodontitis: A Matter of Inflammation
por: Moritz E, et al.
Publicado: (2021) -
Transient Ischemic Attacks Preceding Ischemic Stroke and the Possible Preconditioning of the Human Brain: A Systematic Review and Meta-Analysis
por: Sherief Ghozy, et al.
Publicado: (2021) -
Neuroprotective Effects of Fingolimod in a Cellular Model of Optic Neuritis
por: Amritha A. Candadai, et al.
Publicado: (2021)